GALAPAGOS

At Galapagos, we are united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life across the globe... Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology. BridGene is a biotechnology company that uses proprietary chemoproteomics technology to discover novel small molecule drug candidates... We are a biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation for more years of life and quality of life.

Also known as: Galapagos NV

Registration numbers: 0466.460.429 (W)

VAT numbers: BE 0466.460.429

Primary location: Beaconsfield United Kingdom